Multicentre, Open, Non-randomised Controlled Phase IV Clinical Trial of Efficacy and Safety for Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus Using Also Insulin Glargine.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2012
At a glance
- Drugs Insulin glargine; Insulin glulisine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PORTAL 1
- Sponsors Sanofi
- 10 Jun 2017 Biomarkers information updated
- 16 Jul 2012 Actual initiation date changed from Aug 2009 to Jul 2009 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.